London Daily

Focus on the big picture.
Monday, Oct 05, 2026

World Health Organisation warns countries not to treat Covid-19 patients with unproven medicine amid scramble for a cure

History of medicine abounds with ‘examples of drugs that worked on paper or in a test tube but were actually harmful’, WHO chief says. Warning comes as cases of the respiratory ailment caused by the coronavirus surge worldwide

The World Health Organisation (WHO) on Friday warned governments against treating infected coronavirus patients with medications not scientifically proven to fight the pathogen.

WHO Director General Tedros Adhanom Ghebreyesus issued the warning as cases of Covid-19, the respiratory ailment caused by the coronavirus that emerged in China late last year, surged worldwide, prompting health authorities to scramble to find treatments.

“We call on all individuals and countries to refrain from using therapeutics that have not been demonstrated to be effective in the treatment of Covid-19,” Tedros said. “The history of medicine is strewn with examples of drugs that worked on paper, or in a test tube, but didn't work in humans, or were actually harmful.”

“During the most recent Ebola epidemic, for example, some medicines that were thought to be effective were found not to be as effective as other medicines, when they were compared during a clinical trial,” he said. “We must follow the evidence. There are no short cuts.”

Tedros did not name any individuals, including US President Donald Trump, who came under criticism for touting chloroquine – a medicine for malaria – as a treatment for Covid-19 patients.

Trump defended his aim to start using the medicine regardless of the WHO warning.

Asked in a White House briefing about whether he would continue pushing chloroquine as a treatment, Trump said: “We have people dying now.”

“If we're going to go into labs and test all of this for a long time, we can test it on people right now who are in serious trouble who would dying,” Trump said. “If it works, we've done a great thing. If it doesn't work, you know, we tried.”

The US leader began pushing for chloroquine as a treatment last week.

In a press briefing on March 19, Trump, referring to the medication, said: “Normally the [US Food and Drug Administration] would take a long time to approve something like that, and it was approved very, very quickly and it's now approved, by prescription.”

Soon after Trump’s comments, the FDA said that chloroquine had not been approved for treating Covid-19 and that more tests were needed to determine its safety and effectiveness.

A day later, US infectious disease expert Dr. Anthony Fauci said evidence that chloroquine worked against Sars-CoV-2, the scientific name for the new coronavirus, was “anecdotal”.

The effort to prove the medication’s efficacy against the contagion, he said, “was not done in a controlled clinical trial, so you really can’t make any definitive statement about it”.

Many US media outlets have reported shortages of chloroquine and hydroxychloroquine, a newer derivative of chloroquine that is also used for malaria, since Covid-19 cases began to surge in the country.

Tedros also warned that “off-label” usage of medication – the prescribing of sanctioned drugs for other, unapproved purposes – to treat Covid-19 potentially threatens the health of many individuals not infected with the new illness.

“We need to ensure that using unproven drugs does not create a shortage of those medicines to treat diseases for which they have proven effective,” the head of the UN agency said in the briefing.

Newsletter

Related Articles

0:00
0:00
Close
BT Accused of Pressuring Vulnerable Customers During Digital Landline Shift
British Carmakers Warn of Growing Pressure From EU-China Tariff Dispute
Green Party of England and Wales Adopts Motion Defining Zionism as Racism
Medical Charity Threatens NHS Legal Action Over Two-Year Autism and ADHD Assessment Waits
British Transport Police Report Record Rise in Violence on Railways
Glasgow Council Workers Face Pay Cuts Under Fire-and-Rehire Plan
British Medical Groups Press Prime Minister Andy Burnham to Cancel £330 Million Palantir NHS Contract
UK Faces Record Bluetongue Outbreak Across Livestock Farms
UK Schools Report Thousands of Child-on-Child Sexual Offences
High Court Overturns Ban Blocking Gaza Families From Reuniting With Relatives in UK
G7 Authorizes Emergency Fuel Release as UK Diesel Prices Hit £2 a Litre
France and Italy Draw 1-1 in Nations League Match
Pope Leo XIV and Prince Albert II of Monaco Meet in Metz
SNCF Expands Low-Cost Ouigo High-Speed Service Between Lyon and Bordeaux
Paris Expands Dedicated Cargo Bike Routes for Urban Deliveries
French Film Industry Pushes for Tighter Streaming Investment Rules
Marseille Court Hands Down Prison Terms in Public Procurement Corruption Case
LVMH and Kering Rely on US Demand as Chinese Luxury Spending Slows
Toulouse Aerospace Sector Launches €80 Million Modernization Fund
Javier Milei Courts French Investment in LNG and Lithium
Mistral AI Launches Sovereign Model for European Public Services
French Competition Authority Fines Retailers €40 Million Over Misleading Promotions
France Records Exceptional Electricity Exports as Nuclear Output Recovers
Dassault Aviation Expands Rafale Assembly Capacity at Mérignac
Sanofi Invests €1 Billion in New Biologics Production Hub Near Lyon
France Protests Germany’s Extension of Border Controls Into 2027
French Public-Sector and Transport Unions Threaten National Strike
France Deploys Riot Police After Violence in Lyon Suburbs
French Anti-Terrorism Prosecutors Investigate Radicalized Flydubai Co-Pilot
France’s Defense Budget Surpasses NATO’s 2% of GDP Target
French Government Faces No-Confidence Threat Over Budget
France and G7 Release 100 Million Barrels From Strategic Oil Reserves
France Convenes Emergency Defense Council Over Threats to Commercial Shipping
France and Germany Coordinate Military Response After Russian Strikes on Kyiv Infrastructure
UK Police Release Six Iranian Nationals on Bail After RAF Fairford Security Alert
UK Business Confidence Falls as Energy Costs and Tax Uncertainty Rise
Cornwall Insight Warns UK Energy Bills Could Rise 16% in January
UK Introduces Zero VAT on Household Electricity Bills
UK 30-Year Gilt Yield Hits 6% as Bond Market Pressures Intensify
UK Introduces Stricter Subcontractor Checks and Expanded Trade Union Access
Green Party Proposes Three-Year Emergency Freeze on Private Rent Increases
UK Treasury Committee Seeks Tax Clarification Over Manchester City Investigation
Royal Marines Deploy to Faroe Islands for Northern European Security Exercise
UK Business Confidence Weakens as High Costs Delay Investment
UK GDP Growth Revised Up to 0.5% in Second Quarter
Bank of England Warns of Financial Stability Risks From Autonomous AI
UK Expands Early Prisoner Release Scheme to Ease Overcrowding
UK Records Worst Bluetongue Outbreak on Record Across Livestock Farms
UK Government Faces Shrinking Fiscal Headroom Ahead of October 28 Budget
UK 30-Year Gilt Yield Reaches 6% as Energy Shock Drives Borrowing Costs Higher
×